Literature DB >> 8170554

Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group.

G Savettieri1, W A Rocca, G Salemi, F Meneghini, F Grigoletto, L Morgante, A Reggio, V Costa, M A Coraci, R Di Perri.   

Abstract

In a door-to-door survey conducted in two municipalities of Sicily, we ascertained the prevalence of diabetic neuropathy. Our case-finding was restricted to subjects with somatic symptoms. During phase 1, we administered a screening instrument for peripheral neuropathy to 14,540 persons residing in Santa Teresa di Riva (Messina Province) and Terrasini (Palermo Province). During phase 2, neurologists evaluated those subjects who had screened positive. Diagnoses were based on clinical criteria only, and were reviewed by an adjudication panel. We found 39 persons (27 women, 12 men) affected by diabetic neuropathy. The crude prevalence, as of November 1, 1987, was 268.2 cases per 100,000 population. The prevalence increased with advancing age for both sexes and was consistently higher in women. The most common type was distal symmetric polyneuropathy. The median time between diagnosis of diabetes mellitus and onset of diabetic neuropathy was 8 years, and almost all identified persons with diabetic neuropathy were under treatment for diabetes mellitus.

Entities:  

Mesh:

Year:  1993        PMID: 8170554     DOI: 10.1212/wnl.43.6.1115

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Tests and expenditures in the initial evaluation of peripheral neuropathy.

Authors:  Brian Callaghan; Ryan McCammon; Kevin Kerber; Xiao Xu; Kenneth M Langa; Eva Feldman
Journal:  Arch Intern Med       Date:  2012-01-23

2.  Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts?

Authors:  Brian C Callaghan; James F Burke; Ann Rodgers; Ryan McCammon; Kenneth M Langa; Eva L Feldman; Kevin A Kerber
Journal:  Neurol Clin Pract       Date:  2013-10

3.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

4.  Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy.

Authors:  Brian C Callaghan; Kevin A Kerber; Lynda L Lisabeth; Lewis B Morgenstern; Ruth Longoria; Ann Rodgers; Paxton Longwell; Eva L Feldman
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

Review 5.  Diabetic neuropathy: clinical manifestations and current treatments.

Authors:  Brian C Callaghan; Hsinlin T Cheng; Catherine L Stables; Andrea L Smith; Eva L Feldman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

6.  Impairments and comorbidities of polyneuropathy revealed by population-based analyses.

Authors:  E Matthew Hoffman; Nathan P Staff; Jared M Robb; Jennifer L St Sauver; Peter J Dyck; Christopher J Klein
Journal:  Neurology       Date:  2015-04-01       Impact factor: 9.910

7.  The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice.

Authors:  Brian C Callaghan; Kevin Kerber; Andrea L Smith; A Mark Fendrick; Eva L Feldman
Journal:  Arch Neurol       Date:  2011-11-14

Review 8.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 9.  Distal Symmetric Polyneuropathy: A Review.

Authors:  Brian C Callaghan; Raymond S Price; Eva L Feldman
Journal:  JAMA       Date:  2015-11-24       Impact factor: 56.272

Review 10.  The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.

Authors:  Brian Callaghan; Eva Feldman
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.